Considering the high dependence on OXPHOS of MLL/AF9 AML cells, we determined the response of various AML cell lines to metformin and found that THP1 and MOLM13 cells were more sensitive to metformin treatment. This evidence concerns the gene MLLT3 and acute myeloid leukemia.